ArticleAnnals of surgical oncology2014

Bevacizumab efficacy in metastatic colorectal cancer is dependent on primary tumor resection.

Francois Ghiringhelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.